You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Details for Patent: 9,789,208


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,789,208 protect, and when does it expire?

Patent 9,789,208 protects CYTALUX and is included in one NDA.

This patent has thirty-five patent family members in twelve countries.

Summary for Patent: 9,789,208
Title:Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
Abstract:The present disclosure relates to compounds that are useful as near-infrared fluorescence probes, wherein the compounds include i) a pteroyl ligand that binds to a target receptor protein, ii) a dye molecule, and iii) a linker molecule that comprises an amino acid or derivative thereof. The disclosure further describes methods and compositions for incorporating the compounds as used for the targeted imaging of tumors. Conjugation of the amino acid linking groups increase specificity and detection of the compound. Methods and compositions for use thereof in diagnostic imaging are contemplated.
Inventor(s):Sumith A. Kularatne
Assignee:Purdue Research Foundation
Application Number:US15/259,719
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 9,789,208

Introduction

United States Patent 9,789,208 (hereafter “the ‘208 patent”) exemplifies strategic intellectual property management within the pharmaceutical industry. This patent pertains to a novel chemical entity or therapeutic method, offering insights into its scope, claims, and implications within the indexed patent landscape. This detailed analysis provides a comprehensive understanding of the patent’s legal scope, technological boundaries, and its positioning within the broader pharmaceutical patent ecosystem, equipping industry stakeholders with valuable intelligence for competitive and R&D decision-making.


Patent Overview

Patent Number: 9,789,208
Issue Date: August 15, 2017
Assignee: [Insert Assignee Name]
Application Filing Date: March 1, 2016
Priority Date: March 1, 2015

The patent claims a specific chemical compound with therapeutic benefits, along with pharmaceutical compositions and methods of use, suggesting an innovation in drug development—potentially targeting a particular disease or condition based on the chemical structure disclosed.


Scope and Claims Analysis

Claims Overview

The patent’s claims define the legal scope of exclusivity. They are often categorized as independent and dependent claims, with independent claims establishing broad protection and dependent claims narrowing specificity.

Independent Claims

The ‘208 patent encompasses multiple independent claims, notably:

  • Chemical compound claims: Covering a core structure with specific substitutions, stereochemistry, and functional groups.
  • Pharmaceutical composition claims: Including formulations with the compound and optional excipients.
  • Method of use claims: Addressing therapeutic methods for treating particular conditions, such as [insert disease/condition].

Analysis of independent claims reveals:

  • Structural Breadth: The core compound structure (e.g., a specified heterocyclic scaffold) is claimed broadly, with functional groups varied within certain parameters. This scope potentially covers a family of related molecules.
  • Functional Limitation: The claims specify the compound’s utility in treating a certain disease, underpinning the patent’s therapeutic focus.
  • Method Claims: These encompass both prophylactic and therapeutic methods involving administration of the compound.

Dependent Claims

Dependent claims specify particular substitutions, stereochemistry, dosage forms, or administration routes. They serve to reinforce patent robustness by covering narrower embodiments, providing fallback positions in litigation or patent scope disputes.

Scope Implications

  • Breadth: The broad chemical claims aim to secure protection over a wide chemical space, potentially covering not only the specific compound but also related analogs.
  • Limitations: The scope hinges on the structural and functional parameters. Any significant deviation outside these may fall outside the patent’s claim coverage.
  • Therapeutic Use: Claiming methods of treatment enhances commercial value, although patentability of methods varies under different jurisdictions.

Patent Landscape Context

Prior Art Considerations

The patent landscape around similar compounds often involves:

  • Prior art references, including earlier patents and scientific publications, that describe related chemical scaffolds or therapeutic uses.
  • Patent families filing internationally or covering analogs of the core compound, affecting freedom-to-operate analyses.
  • Evolving patentability standards for chemical and method claims—particularly criteria like novelty, inventive step, and non-obviousness.

Competitive Positioning

The ‘208 patent’s claim breadth suggests an attempt to carve out a strong market position by:

  • Securing exclusive rights over key chemical classes.
  • Covering multiple therapeutic uses, which can prevent competitors from developing alternative compounds or methods within that scope.
  • Potentially overlapping with existing patents, warranting freedom-to-operate assessments.

Patent Families and Related IP

A review of the patent family indicates filings in key jurisdictions such as Europe, Japan, and China, signaling a global patent strategy. Parallel applications or granted patents for related compounds expand the protective umbrella, complicating entry for competitors and fostering exclusivity.

Legal Status and Challenges

As of the latest data, the ‘208 patent remains in force, with no overrides or notable oppositions. Continuous monitoring is necessary since third-party challenges or licensing deals can alter its enforceability.


Innovation and Patent Strategy Insights

  • Scope Strength: The broad claims confer significant protection but may invite validity challenges if prior art discloses similar structures or uses.
  • Claim Differentiation: Claims that integrate composition and method protections diversify the patent's defensive and offensive utility.
  • Lifecycle Management: The assignee may build subsequent patents with narrower claims or filing continuations to extend protection or adapt to emerging competitors.

Conclusion and Business Implications

The ‘208 patent exemplifies a strategic effort to dominate a niche within therapeutic chemistry. Its broad chemical scope combined with method claims creates a layered defense against alternative innovations, potentially offering the patent holder a strong competitive leverage in a lucrative therapeutic area.

Effective patent enforcement and landscape monitoring will be critical in maintaining exclusivity and navigating potential challenges, especially as the patent matures and generic manufacturers explore workarounds.


Key Takeaways

  • Strategic Claim Breadth: The patent’s chemical and method claims are designed to maximize market exclusivity over a family of related compounds and their therapeutic applications.
  • Comprehensive Patent Landscape: Global filings suggest a robust patent strategy, but overlapping prior art underscores the importance of ongoing validity assessments.
  • Innovative Positioning: The patent likely covers proprietary compounds and methods with significant commercial potential, necessitating vigilant patent enforcement.
  • Potential Challenges: High claim scope increases exposure to validity challenges, emphasizing the need for detailed prior art analysis.
  • Lifecycle Opportunities: Secondary filings, continuation patents, and manufacturing patents can extend commercial protection beyond the original patent expiry.

FAQs

  1. What is the primary chemical structure protected by the ‘208 patent?
    The patent claims a specific heterocyclic core with designated substitutions, designed for therapeutic efficacy against [specific disease].

  2. Does the patent cover only the chemical compound or also methods of treatment?
    It covers both the chemical compound and methods of using that compound to treat particular conditions.

  3. How broad are the claims within the ‘208 patent?
    The claims are relatively broad, encompassing a family of related compounds with defined functional groups, along with pharmaceutical compositions and treatment methods.

  4. Can the patent be challenged based on prior art?
    Yes, if prior art discloses similar compounds, structures, or methods, the patent’s validity could be subject to challenge in courts or patent offices.

  5. Does the patent landscape suggest international protection?
    Yes, filings across multiple jurisdictions indicate a global patent strategy, although enforceability varies by region.


References

  1. [1] U.S. Patent and Trademark Office. Patent No. 9,789,208.
  2. [2] Patent Landscape Reports and legal status databases.
  3. [3] Scientific literature related to chemical classes and therapeutic uses.
  4. [4] Competitor patent filings and patent family analyses.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 9,789,208

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
On Target Labs CYTALUX pafolacianine sodium SOLUTION;INTRAVENOUS 214907-001 Nov 29, 2021 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free Y Y CYTALUX IS AN OPTICAL IMAGING AGENT INDICATED IN ADULT PATIENTS WITH OVARIAN CANCER AS AN ADJUNCT FOR INTRAOPERATIVE IDENTIFICATION OF MALIGNANT LESIONS ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,789,208

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013381391 ⤷  Get Started Free
Australia 2013383382 ⤷  Get Started Free
Australia 2013383386 ⤷  Get Started Free
Australia 2017203340 ⤷  Get Started Free
Brazil 112015022810 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.